Cargando…
COVID-19: Mechanisms of Vaccination and Immunity
Vaccines are needed to protect from SARS-CoV-2, the virus causing COVID-19. Vaccines that induce large quantities of high affinity virus-neutralizing antibodies may optimally prevent infection and avoid unfavorable effects. Vaccination trials require precise clinical management, complemented with de...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564472/ https://www.ncbi.nlm.nih.gov/pubmed/32707833 http://dx.doi.org/10.3390/vaccines8030404 |
_version_ | 1783595722881368064 |
---|---|
author | Speiser, Daniel E. Bachmann, Martin F. |
author_facet | Speiser, Daniel E. Bachmann, Martin F. |
author_sort | Speiser, Daniel E. |
collection | PubMed |
description | Vaccines are needed to protect from SARS-CoV-2, the virus causing COVID-19. Vaccines that induce large quantities of high affinity virus-neutralizing antibodies may optimally prevent infection and avoid unfavorable effects. Vaccination trials require precise clinical management, complemented with detailed evaluation of safety and immune responses. Here, we review the pros and cons of available vaccine platforms and options to accelerate vaccine development towards the safe immunization of the world’s population against SARS-CoV-2. Favorable vaccines, used in well-designed vaccination strategies, may be critical for limiting harm and promoting trust and a long-term return to normal public life and economy. |
format | Online Article Text |
id | pubmed-7564472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75644722020-10-26 COVID-19: Mechanisms of Vaccination and Immunity Speiser, Daniel E. Bachmann, Martin F. Vaccines (Basel) Review Vaccines are needed to protect from SARS-CoV-2, the virus causing COVID-19. Vaccines that induce large quantities of high affinity virus-neutralizing antibodies may optimally prevent infection and avoid unfavorable effects. Vaccination trials require precise clinical management, complemented with detailed evaluation of safety and immune responses. Here, we review the pros and cons of available vaccine platforms and options to accelerate vaccine development towards the safe immunization of the world’s population against SARS-CoV-2. Favorable vaccines, used in well-designed vaccination strategies, may be critical for limiting harm and promoting trust and a long-term return to normal public life and economy. MDPI 2020-07-22 /pmc/articles/PMC7564472/ /pubmed/32707833 http://dx.doi.org/10.3390/vaccines8030404 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Speiser, Daniel E. Bachmann, Martin F. COVID-19: Mechanisms of Vaccination and Immunity |
title | COVID-19: Mechanisms of Vaccination and Immunity |
title_full | COVID-19: Mechanisms of Vaccination and Immunity |
title_fullStr | COVID-19: Mechanisms of Vaccination and Immunity |
title_full_unstemmed | COVID-19: Mechanisms of Vaccination and Immunity |
title_short | COVID-19: Mechanisms of Vaccination and Immunity |
title_sort | covid-19: mechanisms of vaccination and immunity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564472/ https://www.ncbi.nlm.nih.gov/pubmed/32707833 http://dx.doi.org/10.3390/vaccines8030404 |
work_keys_str_mv | AT speiserdaniele covid19mechanismsofvaccinationandimmunity AT bachmannmartinf covid19mechanismsofvaccinationandimmunity |